Pharmacist-directed vancomycin therapeutic drug monitoring in pediatric patients: a collaborative-practice model
Abstract Background Therapeutic drug monitoring (TDM) of Vancomycin (VCM) is required to prevent inappropriate dosage-associated bacterial resistance, therapeutic failure, and toxicities in pediatrics. Anecdotal experience and studies show that many healthcare institutions confront barriers while im...
Guardado en:
Autores principales: | Kashif Hussain, Rahila Ikram, Gul Ambreen, Muhammad Sohail Salat |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d8a77add683043fc942fb818ac2a6fe7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Assessment of pharmacists' perception toward continuing education
por: Nouf M Alharthi, et al.
Publicado: (2021) -
Cerebrospinal Fluid Concentrations of Meropenem and Vancomycin in Ventriculitis Patients Obtained by TDM-Guided Continuous Infusion
por: Christoph Tiede, et al.
Publicado: (2021) -
Pharmacists and telemedicine: an innovative model fulfilling Sustainable Development Goals (SDGs)
por: Nadia Bukhari, et al.
Publicado: (2021) -
Bibliometric analysis of pharmacist’s research on antimicrobial stewardship in Japan: an interrupted time series analysis on the implementation of the certification system for infection control pharmacists
por: Masayuki Maeda, et al.
Publicado: (2021) -
Physicians' views on cardiovascular disease risk prevention services by pharmacists and potential for collaboration
por: Hadi A. Almansour, et al.
Publicado: (2021)